The Hunt for New Checkpoint Inhibitors - Amgen Science

Amgen is using human genetics and cutting-edge biology to search for new checkpoint targets that will work in more types of cancer and more patients.
More about Amgen Research:
www.amgen.com
Immunotherapy is the art taking your bodies immune system and diverting it to help kill cancer cells. While immunotherapy has made great progress, it is still only able to fight a small percentage of cancers and still has a long way to go.
Amgen's BiTE molecules are advancing through clinical studies combine with new checkpoint molecules that monitor the response to cancer.
Find Amgen on the Web:
Facebook: bit.ly/35Xf09E
Instagram: bit.ly/2SYnTKJ
Twitter: bit.ly/2SW2cLq
LinkedIn: bit.ly/2xWbS17